XML 95 R61.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2

Fair value of financial instruments and investments - Fair Value Liabilities Measured (Details) $ in Thousands	Dec. 31, 2019 USD ($) $ / shares	Dec. 31, 2018 USD ($) $ / shares	Dec. 31, 2017 USD ($)
Stock Appreciation Rights (SARs)
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	$ 3,186	$ 3,814
Minimum | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input | $ / shares	6.76	6.76
Minimum | Volatility | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input	0.2893	0.4653
Minimum | Risk free interest rate | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input	0.0019	0.0244
Minimum | Expected life | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input	0.01	0.01
Maximum | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input | $ / shares	30.86	30.86
Maximum | Volatility | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input		0.5959
Maximum | Risk free interest rate | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input		0.0263
Maximum | Expected life | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Measurement input	1.01	1.01
Significant unobservable inputs (level 3) | Stock Appreciation Rights (SARs)
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	$ 3,186	$ 3,814	$ 1,665
Significant unobservable inputs (level 3) | Agilis
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	65,800
Liability, Development and Regulatory Milestone | Agilis
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	290,500	257,040
Liability, Development and Regulatory Milestone | Agilis | Minimum | Potential development and regulatory milestones | Commitments
Fair value of warrant liability
Milestone		$ 0
Liability, Development and Regulatory Milestone | Agilis | Minimum | Potential net sales milestones | Commitments
Fair value of warrant liability
Milestone	$ 0
Liability, Development and Regulatory Milestone | Agilis | Minimum | Probabilities of success | Commitments
Fair value of warrant liability
Measurement input	0.25	0.25
Liability, Development and Regulatory Milestone | Agilis | Minimum | Potential percentage of net sales for royalties | Commitments
Fair value of warrant liability
Measurement input	0.02
Liability, Development and Regulatory Milestone | Agilis | Minimum | Discount rate | Commitments
Fair value of warrant liability
Measurement input		0.058
Liability, Development and Regulatory Milestone | Agilis | Maximum | Potential development and regulatory milestones | Commitments
Fair value of warrant liability
Milestone		$ 555,000
Liability, Development and Regulatory Milestone | Agilis | Maximum | Potential net sales milestones | Commitments
Fair value of warrant liability
Milestone	$ 150,000
Liability, Development and Regulatory Milestone | Agilis | Maximum | Probabilities of success | Commitments
Fair value of warrant liability
Measurement input	0.89	0.94
Liability, Development and Regulatory Milestone | Agilis | Maximum | Potential percentage of net sales for royalties | Commitments
Fair value of warrant liability
Measurement input	0.06
Liability, Development and Regulatory Milestone | Agilis | Maximum | Discount rate | Commitments
Fair value of warrant liability
Measurement input		0.080
Liability, Development and Regulatory Milestone | Significant unobservable inputs (level 3) | BioElectron | Commitments
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	$ 290,500	$ 257,040	0
Liability, Net Sales Milestones and Royalties | Agilis
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	$ 65,800	$ 53,200
Liability, Net Sales Milestones and Royalties | Agilis | Discount rate | Commitments
Fair value of warrant liability
Measurement input	0.145	0.140
Liability, Net Sales Milestones and Royalties | Agilis | Minimum | Potential development and regulatory milestones | Commitments
Fair value of warrant liability
Milestone	$ 0
Liability, Net Sales Milestones and Royalties | Agilis | Minimum | Potential net sales milestones | Commitments
Fair value of warrant liability
Milestone		$ 0
Liability, Net Sales Milestones and Royalties | Agilis | Minimum | Probabilities of success | Commitments
Fair value of warrant liability
Measurement input	0.25	0.25
Liability, Net Sales Milestones and Royalties | Agilis | Minimum | Potential percentage of net sales for royalties | Commitments
Fair value of warrant liability
Measurement input		0.02
Liability, Net Sales Milestones and Royalties | Agilis | Minimum | Discount rate | Commitments
Fair value of warrant liability
Measurement input	0.022
Liability, Net Sales Milestones and Royalties | Agilis | Maximum | Potential development and regulatory milestones | Commitments
Fair value of warrant liability
Milestone	$ 555,000
Liability, Net Sales Milestones and Royalties | Agilis | Maximum | Potential net sales milestones | Commitments
Fair value of warrant liability
Milestone		$ 150,000
Liability, Net Sales Milestones and Royalties | Agilis | Maximum | Probabilities of success | Commitments
Fair value of warrant liability
Measurement input	0.94	0.89
Liability, Net Sales Milestones and Royalties | Agilis | Maximum | Potential percentage of net sales for royalties | Commitments
Fair value of warrant liability
Measurement input		0.06
Liability, Net Sales Milestones and Royalties | Agilis | Maximum | Discount rate | Commitments
Fair value of warrant liability
Measurement input	0.047
Liability, Net Sales Milestones and Royalties | Significant unobservable inputs (level 3) | BioElectron
Fair value of warrant liability
Contingent consideration payable- net sales milestones and royalties	$ 65,800	$ 53,200	$ 0

X

- Definition

Alternative Investment, Milestone

+ References

No definition available.

+ Details

Name:	ptct_AlternativeInvestmentMilestone
Namespace Prefix:	ptct_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Value of input used to measure alternative investment.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_AlternativeInvestmentMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=us-gaap_StockAppreciationRightsSARSMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ptct_AgilisMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=ptct_LiabilityDevelopmentandRegulatoryMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=ptct_DevelopmentandRegulatoryMilestoneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=us-gaap_CommitmentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=ptct_SalesMilestonesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=ptct_ProbabilityofSuccessMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=ptct_PercentageofSalesforRoyaltiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ptct_BioElectronMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=ptct_LiabilityNetSalesMilestonesandRoyaltiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: